Cost-effectiveness of hepatic artery infusion for metastatic colorectal cancer (CALGB 9481)

被引：2
|
作者：
Weeks, JC
Romanus, D
Herndon, JE
Schrag, D
Mayer, RJ
Kemeny, N
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] CALGB Stat Ctr, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67251-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of hepatic artery infusion chemotherapy
    Kuvshinoff, BW
    CANCER, 1998, 83 (05) : 837 - 838
  • [2] Cost-effectiveness for metastatic colorectal cancer.
    Yao, Linli
    Han, Jiaqi
    She, Longjiang
    Ding, Dong
    Liao, Mengting
    Hu, Huabin
    Zeng, Shan
    Shen, Liangfang
    Huang, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Cost-effectiveness of hepatic artery chemoembolization for colorectal liver metastases
    Abramson, RG
    Rosen, MP
    Perry, LJ
    Brophy, DP
    Raeburn, SL
    Stuart, K
    RADIOLOGY, 1999, 213P : 243 - 244
  • [4] Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer
    Goldstein, Daniel A.
    Ahmad, Bilal B.
    Chen, Qiushi
    Ayer, Turgay
    Howard, David H.
    Lipscomb, Joseph
    El-Rayes, Bassel F.
    Flowers, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer
    Goldstein, Daniel A.
    Ahmad, Bilal B.
    Chen, Qiushi
    Ayer, Turgay
    Howard, David H.
    Lipscomb, Joseph
    El-Rayes, Bassel F.
    Flowers, Christopher R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3727 - +
  • [6] Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA
    Kang, Dong-Won
    Lynn, Patricio B.
    Wang, Li
    Zhou, Shouhao
    Shen, Chan
    PHARMACOECONOMICS-OPEN, 2024, : 93 - 101
  • [7] Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer
    Sherman, Scott K.
    Lange, Joel J.
    Dahdaleh, Fadi S.
    Rajeev, Rahul
    Gamblin, T. Clark
    Polite, Blase N.
    Turaga, Kiran K.
    JAMA ONCOLOGY, 2019, 5 (02) : 236 - 242
  • [8] Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis
    Goldstein, Daniel A.
    Chen, Qiushi
    Ayer, Turgay
    Chan, Kelvin K. W.
    Virik, Kiran
    Hammerman, Ariel
    Brenner, Baruch
    Flowers, Christopher R.
    Hall, Peter S.
    ONCOLOGIST, 2017, 22 (06): : 694 - 699
  • [9] Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer.
    Goldstein, Daniel A.
    Ahmad, Bilal B.
    Chen, Qiushi
    Ayer, Turgay
    Howard, David H.
    Lipscomb, Joseph
    El-Rayes, Bassel F.
    Flowers, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
    Kemeny, NE
    Niedzwiecki, D
    Hollis, DR
    Lenz, HJ
    Warren, RS
    Naughton, MJ
    Weeks, JC
    Sigurdson, ER
    Herndon, JE
    Zhang, CF
    Mayer, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) : 1395 - 1403
12345